Dolly Vance | Executive Vice President-Corporate Affairs and General Counsel |
Raul Rodriguez | President and Chief Executive Officer |
Dave Santos | Chief Commercial Officer |
Wolfgang Dummer | Executive Vice President and Chief Medical Officer |
Esteban Masuda | Executive Vice President-Research |
Dean Schorno | Executive Vice President and Chief Financial Officer |
Yigal Nochomovitz | Citigroup |
Eun Yang | Jefferies |
Do Kim | BMO Capital Markets |
Chris Raymond | Piper Sandler |
Kristen Kluska | Cantor Fitzgerald |
Emanuela Branchetti | H.C. Wainwright |
Greetings, and welcome to the Rigel Pharmaceuticals’ Financial Conference Call for the Fourth Quarter and Year-End 2020. At this time, all participants are in a listen-only mode. [Operator Instructions] As a reminder, this conference is being recorded. It’s now my pleasure to introduce our first speaker, Dolly Vance, who is Rigel’s Executive Vice President, Corporate Affairs and General Counsel. Thank you, Ms.